NO20045536L - Inhibitorer av inflammatorisk genaktivitet og kolesterol-biosyntese - Google Patents
Inhibitorer av inflammatorisk genaktivitet og kolesterol-biosynteseInfo
- Publication number
- NO20045536L NO20045536L NO20045536A NO20045536A NO20045536L NO 20045536 L NO20045536 L NO 20045536L NO 20045536 A NO20045536 A NO 20045536A NO 20045536 A NO20045536 A NO 20045536A NO 20045536 L NO20045536 L NO 20045536L
- Authority
- NO
- Norway
- Prior art keywords
- inhibitors
- gene activity
- cholesterol biosynthesis
- methods
- inflammatory gene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
Abstract
Fremgangsmåter for å identifisere agenser effektive som inhibitorer for short heterodimer protein (SHP) og farnesoid X reseptor (FXR) og promotere, cellelinjer og vektorer anvendt i nevnte fremgangsmåter. Fremgangsmåter for fremstilling og anvendelse av agensene effektive som inhibitorer for short heterodimer protein (SHP), omfattende fremgangsmåter for anvendelse av de samme for å forebygge og/eller behandle en tilstand assosiert med inflammatorisk genaktivitet og/eller kolesterol-biosyntese i et subjekt. Agenser effektive som inhibitorer for short heterodimer protein (SHP) eller farnesoid X reseptor (FXR) og sammensetninger omfattende samme, inkluderer sammensetninger effektive i redusering av inflammatorisk genaktivitet og/eller kolesterol-biosyntese i et subjekt.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38791502P | 2002-06-13 | 2002-06-13 | |
US47018803P | 2003-05-14 | 2003-05-14 | |
PCT/US2003/018651 WO2003106632A2 (en) | 2002-06-13 | 2003-06-13 | Inhibitors of inflammatory gene activity and cholesterol biosynthesis |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20045536L true NO20045536L (no) | 2005-02-28 |
Family
ID=34425702
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20045536A NO20045536L (no) | 2002-06-13 | 2004-12-17 | Inhibitorer av inflammatorisk genaktivitet og kolesterol-biosyntese |
Country Status (10)
Country | Link |
---|---|
US (1) | US20050221328A1 (no) |
EP (1) | EP1560925A4 (no) |
JP (1) | JP2006505249A (no) |
KR (1) | KR20050010916A (no) |
CN (1) | CN1675376A (no) |
BR (1) | BR0311772A (no) |
CA (1) | CA2489594A1 (no) |
EA (1) | EA200500012A1 (no) |
MX (1) | MXPA04012560A (no) |
NO (1) | NO20045536L (no) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090137516A1 (en) * | 2007-11-05 | 2009-05-28 | Wyeth | Compositions and methods of treating dyslipidemia |
WO2009141926A1 (ja) * | 2008-05-23 | 2009-11-26 | 国立大学法人東京大学 | 糖代謝・脂質代謝に作用する化合物の取得方法 |
RU2705249C2 (ru) * | 2013-07-12 | 2019-11-06 | Дзе Чилдрен'З Хоспитал Оф Филадельфия | Вектор aav и анализ на нейтрализующие антитела против aav (аденоассоциированного вируса) |
US10301268B2 (en) * | 2014-03-13 | 2019-05-28 | The Salk Institute For Biological Studies | Analogs of fexaramine and methods of making and using |
US20230174951A1 (en) * | 2020-04-26 | 2023-06-08 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization | Phenol-rich grapes |
CN114022409B (zh) * | 2021-09-30 | 2023-04-18 | 电子科技大学 | 基于深度学习的包覆药表面缺陷检测算法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5753431A (en) * | 1993-10-13 | 1998-05-19 | Northeastern Ohio University | Cholesterol 7 α-hydroxdylase gene regulatory elements and transcription factors |
US5728548A (en) * | 1995-06-29 | 1998-03-17 | Genetics Institute, Inc. | Retinoid receptor-1 (RR1) and DNA encoding RR1 |
US6316181B1 (en) * | 1998-04-24 | 2001-11-13 | Virginia Commonwealth University | Establishment of cell lines with persistent expression of a green fluorescent protein (GFP) using a pIRES/EGFP DNA vector construct |
US20030083484A1 (en) * | 2001-07-31 | 2003-05-01 | Crooke Rosanne M. | Antisense modulation of short heterodimer partner-1 expression |
AU4948800A (en) * | 1999-05-24 | 2000-12-12 | Sankyo Company Limited | Method for searching physiologically active substance |
WO2001053312A1 (en) * | 1999-12-23 | 2001-07-26 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
WO2001079224A2 (en) * | 2000-04-12 | 2001-10-25 | Genaissance Pharmaceuticals, Inc. | Haplotypes of the cyp8b1 gene |
AU2001280974A1 (en) * | 2000-07-31 | 2002-02-13 | Glaxo Group Limited | Identification of new therapeutic targets for modulating bile acid synthesis |
US6878751B1 (en) * | 2000-10-19 | 2005-04-12 | Imperial College Of Science Technology And Medicine | Administration of resveratrol to treat inflammatory respiratory disorders |
-
2003
- 2003-06-13 JP JP2004513445A patent/JP2006505249A/ja active Pending
- 2003-06-13 BR BRPI0311772-3A patent/BR0311772A/pt not_active IP Right Cessation
- 2003-06-13 EA EA200500012A patent/EA200500012A1/ru unknown
- 2003-06-13 MX MXPA04012560A patent/MXPA04012560A/es not_active Application Discontinuation
- 2003-06-13 EP EP03760319A patent/EP1560925A4/en not_active Withdrawn
- 2003-06-13 US US10/517,695 patent/US20050221328A1/en not_active Abandoned
- 2003-06-13 KR KR10-2004-7020311A patent/KR20050010916A/ko not_active Application Discontinuation
- 2003-06-13 CN CNA038194988A patent/CN1675376A/zh active Pending
- 2003-06-13 CA CA002489594A patent/CA2489594A1/en not_active Abandoned
-
2004
- 2004-12-17 NO NO20045536A patent/NO20045536L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2489594A1 (en) | 2003-12-24 |
EP1560925A2 (en) | 2005-08-10 |
US20050221328A1 (en) | 2005-10-06 |
CN1675376A (zh) | 2005-09-28 |
KR20050010916A (ko) | 2005-01-28 |
JP2006505249A (ja) | 2006-02-16 |
EP1560925A4 (en) | 2006-10-25 |
MXPA04012560A (es) | 2005-10-19 |
BR0311772A (pt) | 2007-05-08 |
EA200500012A1 (ru) | 2006-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60336901D1 (de) | Chinazolinon modulatoren von nukleinrezeptoren | |
NO981903L (no) | SmÕ-molekylµre inhibitorer for rotamase enzymaktivitet | |
TW200531679A (en) | Methods of modulating cytokine activity; related reagents | |
WO2003080803A3 (en) | Methods of using farnesoid x receptor (fxr) agonists | |
TR200103428T2 (tr) | IMPDH enzim inhibitörleri. | |
NO20052595L (no) | Sammensetninger anvendelige som inhibitorer av ROCK- og andre proteinkinaser. | |
NO20064976L (no) | Azanidoler som er nyttige som inhibitorer av rock og andre proteinkinaser | |
MX2007004841A (es) | Triazoles utiles como inhibidores de proteinas cinasas. | |
HK1098047A1 (en) | Indole derivatives and use thereof as kinase inhibitors in particular ikk2 inhibitors | |
NO20052888L (no) | Diamintriazoler anvendelige som inhibitorer av proteinkinaser | |
NO20061194L (no) | Mitotiske kinesininbibitorer | |
NO20001583D0 (no) | Stimulering av hematopoetiske celler in vitro | |
EA200700118A1 (ru) | Амидосоединения и их применение в качестве лекарственных средств | |
WO2005001079A3 (en) | Soft tissue repair and regeneration using postpartum-derived cells | |
ZA200509753B (en) | High protein, low carbohydrate pet food composition comprising non-fermentable fiber | |
EA200700251A1 (ru) | Амидосоединения и их применение в качестве фармацевтических средств | |
WO2006055752A3 (en) | INHIBITORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1 AND METHODS OF USING THE SAME | |
SG161286A1 (en) | Methods for treating and preventing fibrosis by il-21 / il-21r antagonists | |
NO991433L (no) | Heterosykliske estere og amider | |
WO2008060813A3 (en) | High affinity antibody antagonists of interleukin-13 receptor alpha 1 | |
LV12125A (lv) | Ciklofilina rotamazes aktivitates inhibitori | |
WO2006071777A3 (en) | Soft tissue repair and regeneration using postpartum-derived cells and cell products | |
NO20014230D0 (no) | Metoder og preparater som anvender (+) noreisaprid i kombinasjon med protonpumpeinhibitorer eller H2 reseptor-antagonister | |
NO20045536L (no) | Inhibitorer av inflammatorisk genaktivitet og kolesterol-biosyntese | |
DK1509618T3 (da) | Autoimmune sygdomme og NADPH-oxidasedefekter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |